CR11492A - Peptidil nitrilos y uso de los mismos como inhibidores de dipeptidil peptidasa i - Google Patents
Peptidil nitrilos y uso de los mismos como inhibidores de dipeptidil peptidasa iInfo
- Publication number
- CR11492A CR11492A CR11492A CR11492A CR11492A CR 11492 A CR11492 A CR 11492A CR 11492 A CR11492 A CR 11492A CR 11492 A CR11492 A CR 11492A CR 11492 A CR11492 A CR 11492A
- Authority
- CR
- Costa Rica
- Prior art keywords
- peptidil
- nitrilos
- inhibitors
- same
- peptidasa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
La presente invencion provee compuestos de formula (I) donde n, y, x1, x2, A, B, R1, R2, R3, R4, Y R5 son como se define en la memoria descriptiva, un proceso para su preparacion.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1297207P | 2007-12-12 | 2007-12-12 | |
PCT/GB2008/051173 WO2009074829A1 (en) | 2007-12-12 | 2008-12-10 | Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11492A true CR11492A (es) | 2010-07-15 |
Family
ID=40364478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11492A CR11492A (es) | 2007-12-12 | 2010-06-11 | Peptidil nitrilos y uso de los mismos como inhibidores de dipeptidil peptidasa i |
Country Status (22)
Country | Link |
---|---|
US (2) | US7902181B2 (es) |
EP (1) | EP2231597A1 (es) |
JP (1) | JP2011506421A (es) |
KR (1) | KR20100098683A (es) |
CN (1) | CN101945851B (es) |
AR (1) | AR069692A1 (es) |
AU (1) | AU2008334444B2 (es) |
BR (1) | BRPI0820665A2 (es) |
CA (1) | CA2706679A1 (es) |
CL (1) | CL2008003694A1 (es) |
CO (1) | CO6280399A2 (es) |
CR (1) | CR11492A (es) |
DO (1) | DOP2010000178A (es) |
EA (1) | EA201000958A1 (es) |
EC (1) | ECSP10010245A (es) |
IL (1) | IL205873A0 (es) |
MX (1) | MX2010006110A (es) |
PE (1) | PE20091100A1 (es) |
TW (1) | TW200932725A (es) |
UY (1) | UY31524A1 (es) |
WO (1) | WO2009074829A1 (es) |
ZA (1) | ZA201004091B (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1976828T (pt) | 2005-12-29 | 2017-03-10 | Celtaxsys Inc | Derivados de diamina como inibidores de leucotrieno a4 hidrolase |
CA2706679A1 (en) * | 2007-12-12 | 2009-06-18 | Astrazeneca Ab | Novel compounds 010 |
WO2010142985A1 (en) * | 2009-06-10 | 2010-12-16 | Astrazeneca Ab | Substituted n-[1-cyano-2-(phenyl)ethyl]piperidin-2-ylcarboxmide compounds 761 |
EP2493571B1 (en) | 2009-10-29 | 2014-07-23 | Janssen Pharmaceutica NV | Alkynyl derivatives useful as dpp-1 inhibitors |
US8552032B2 (en) | 2009-12-18 | 2013-10-08 | Janssen Pharmaceutica Nv | Bicyclic derivatives useful as inhibitors of DPP-1 |
US8481547B2 (en) * | 2009-12-18 | 2013-07-09 | Janssen Pharmaceutica Nv | Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of DPP-1 |
US8686152B2 (en) | 2010-03-10 | 2014-04-01 | Janssen Pharmaceutica Nv | 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (DPP-1) |
ES2532763T3 (es) * | 2010-03-10 | 2015-03-31 | Janssen Pharmaceutica Nv | Derivados de piperidina 4,4-disustituidos útiles como inhibidores de la dipeptidil peptidasa-1 (DPP-1) |
CA2798330A1 (en) | 2010-05-05 | 2011-11-10 | Infinity Pharmaceuticals, Inc. | Tetrazolones as inhibitors of fatty acid synthase |
WO2011154677A1 (en) | 2010-06-09 | 2011-12-15 | Astrazeneca Ab | Substituted n-[1-cyano-2-(phenyl)ethyl] 1-aminocycloalk-1-ylcarboxamide compounds - 760 |
WO2012061926A1 (en) * | 2010-11-08 | 2012-05-18 | Zalicus Pharmaceuticals Ltd. | Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers |
WO2012119941A1 (en) | 2011-03-04 | 2012-09-13 | Prozymex A/S | Peptidyl nitrilcompounds as peptidase inhibitors |
WO2012130299A1 (en) * | 2011-03-30 | 2012-10-04 | Prozymex A/S | Peptidase inhibitors |
US8999975B2 (en) * | 2011-09-19 | 2015-04-07 | Boehringer Ingelheim International Gmbh | Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C |
ES2864862T3 (es) | 2013-03-12 | 2021-10-14 | Celltaxis Llc | Métodos de inhibición de la leucotrieno A4 hidrolasa |
EA029052B1 (ru) | 2013-03-14 | 2018-02-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Замещенные (бензилцианометил)амиды 2-азабицикло[2.2.1]гептан-3-карбоновых кислот в качестве ингибиторов катепсина с |
BR112015022864A8 (pt) | 2013-03-14 | 2019-11-26 | Celtaxsys Inc | composto, composição farmacêutica e uso dos mesmos |
US8889708B2 (en) | 2013-03-14 | 2014-11-18 | Boehringer Ingelheim International Gmbh | Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C |
KR20150127245A (ko) | 2013-03-14 | 2015-11-16 | 켈탁시스, 인코퍼레이티드 | 류코트라이엔 a4 가수분해효소의 저해제 |
JP6441830B2 (ja) * | 2013-03-14 | 2018-12-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | カテプシンcの置換2−アザ−ビシクロ[2.2.1]ヘプタン−3−カルボン酸(シアノ−メチル)−アミド阻害剤 |
CA2906086A1 (en) | 2013-03-14 | 2014-09-25 | Celtaxsys, Inc. | Inhibitors of leukotriene a4 hydrolase |
JP6441831B2 (ja) | 2013-03-14 | 2018-12-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | カテプシンcの置換2−アザ−ビシクロ[2.2.2]オクタン−3−カルボン酸(ベンジル−シアノ−メチル)−アミド阻害剤 |
JP6408008B2 (ja) * | 2013-09-09 | 2018-10-17 | プロザイメックス・アクティーゼルスカブProZymex A/S | ジペプチジルペプチダーゼiインヒビターとしてのペプチジルニトリル化合物 |
NO2699580T3 (es) | 2014-01-24 | 2018-02-24 | ||
JP6529575B2 (ja) | 2014-08-01 | 2019-06-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換オキセタンおよびそれらのカテプシンcの阻害薬としての使用 |
KR102510588B1 (ko) | 2014-09-12 | 2023-03-17 | 베링거 인겔하임 인터내셔날 게엠베하 | 카텝신 c의 스피로사이클릭 억제제 |
DK3239143T3 (da) | 2014-12-24 | 2023-04-11 | Lg Chemical Ltd | Biarylderivat som gpr120-agonist |
WO2016139355A1 (en) | 2015-03-05 | 2016-09-09 | Prozymex A/S | N-substituted 3,3'-(biphenyl-4,4'-diyl)bis-2-aminopropanenitriles as dppi inhibitors |
CA2978234C (en) | 2015-03-05 | 2023-05-02 | Prozymex A/S | Peptidyl nitril compounds as dipeptidyl peptidase i inhibitors |
TWI691486B (zh) * | 2016-01-29 | 2020-04-21 | 日商東麗股份有限公司 | 環狀胺衍生物及其醫藥用途 |
EP3801559A4 (en) | 2018-05-31 | 2022-03-02 | Celltaxis, LLC | METHOD FOR REDUCING LUNG EXACERBATIONS IN PATIENTS SUFFERING FROM RESPIRATORY DISEASE |
KR20230084134A (ko) * | 2020-08-26 | 2023-06-12 | 하이스코 파마수티컬즈 피티이. 엘티디. | 디펩티딜 펩티다제 1의 저해제로서 작용하는 니트릴 유도체 및 이의 용도 |
WO2022117059A1 (zh) | 2020-12-04 | 2022-06-09 | 瑞石生物医药有限公司 | 组织蛋白酶c小分子抑制剂及其医药用途 |
JP2024505715A (ja) * | 2021-02-05 | 2024-02-07 | メッドシャイン ディスカバリー インコーポレイテッド | 1,4-オキサゼパンを含む縮合環誘導体 |
WO2023160541A1 (zh) * | 2022-02-22 | 2023-08-31 | 四川海思科制药有限公司 | 一种含氮杂环化合物的制备方法 |
WO2023160542A1 (zh) * | 2022-02-22 | 2023-08-31 | 四川海思科制药有限公司 | 二肽基肽酶抑制剂化合物的盐及晶型 |
WO2024008680A1 (en) * | 2022-07-06 | 2024-01-11 | Chiesi Farmaceutici S.P.A. | Azetidine derivatives and use thereof as dipeptidyl peptidase 1 inhibitors |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
JP2003506364A (ja) | 1999-07-30 | 2003-02-18 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | システインプロテアーゼインヒビターとして有益な新規スクシネート誘導体化合物 |
CN1240681C (zh) | 1999-12-24 | 2006-02-08 | 霍夫曼-拉罗奇有限公司 | 作为组织蛋白酶k抑制剂的腈衍生物 |
DE60222667T2 (de) * | 2001-06-27 | 2008-07-17 | Smithkline Beecham Corp. | Fluorpyrrolidine als dipeptidylpeptidaseinhibitoren |
DE60221983T2 (de) | 2001-06-27 | 2008-05-15 | Smithkline Beecham Corp. | Fluorpyrrolidine als dipeptidyl-peptidase inhibitoren |
BR0309719A (pt) * | 2002-04-30 | 2005-02-09 | Ucb Sa | Composto ou um sal deste farmaceuticamente aceitável, composição farmacêutica, uso do composto, e, intermediários de sìntese |
WO2004110988A1 (en) | 2003-06-18 | 2004-12-23 | Prozymex A/S | Protease inhibitors |
JP2007522225A (ja) * | 2004-02-10 | 2007-08-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | A4インテグリン拮抗薬としてのピリダジノン |
US7504413B2 (en) * | 2004-05-06 | 2009-03-17 | Cytokinetics, Inc. | N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
CA2706679A1 (en) * | 2007-12-12 | 2009-06-18 | Astrazeneca Ab | Novel compounds 010 |
-
2008
- 2008-12-10 CA CA2706679A patent/CA2706679A1/en not_active Abandoned
- 2008-12-10 KR KR1020107015188A patent/KR20100098683A/ko not_active Application Discontinuation
- 2008-12-10 AU AU2008334444A patent/AU2008334444B2/en not_active Ceased
- 2008-12-10 US US12/331,719 patent/US7902181B2/en not_active Expired - Fee Related
- 2008-12-10 EA EA201000958A patent/EA201000958A1/ru unknown
- 2008-12-10 MX MX2010006110A patent/MX2010006110A/es not_active Application Discontinuation
- 2008-12-10 JP JP2010537526A patent/JP2011506421A/ja active Pending
- 2008-12-10 BR BRPI0820665A patent/BRPI0820665A2/pt not_active IP Right Cessation
- 2008-12-10 EP EP08860193A patent/EP2231597A1/en not_active Withdrawn
- 2008-12-10 WO PCT/GB2008/051173 patent/WO2009074829A1/en active Application Filing
- 2008-12-10 CN CN2008801266467A patent/CN101945851B/zh not_active Expired - Fee Related
- 2008-12-11 UY UY31524A patent/UY31524A1/es unknown
- 2008-12-11 TW TW097148183A patent/TW200932725A/zh unknown
- 2008-12-11 CL CL2008003694A patent/CL2008003694A1/es unknown
- 2008-12-12 AR ARP080105431A patent/AR069692A1/es unknown
- 2008-12-12 PE PE2008002065A patent/PE20091100A1/es not_active Application Discontinuation
-
2010
- 2010-05-20 IL IL205873A patent/IL205873A0/en unknown
- 2010-05-26 CO CO10063301A patent/CO6280399A2/es not_active Application Discontinuation
- 2010-06-08 ZA ZA2010/04091A patent/ZA201004091B/en unknown
- 2010-06-11 CR CR11492A patent/CR11492A/es not_active Application Discontinuation
- 2010-06-11 EC EC2010010245A patent/ECSP10010245A/es unknown
- 2010-06-11 DO DO2010000178A patent/DOP2010000178A/es unknown
-
2011
- 2011-02-11 US US13/025,902 patent/US20110201581A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20100098683A (ko) | 2010-09-08 |
ZA201004091B (en) | 2011-11-30 |
IL205873A0 (en) | 2010-11-30 |
CA2706679A1 (en) | 2009-06-18 |
US7902181B2 (en) | 2011-03-08 |
CN101945851B (zh) | 2012-10-31 |
US20090306042A1 (en) | 2009-12-10 |
BRPI0820665A2 (pt) | 2018-05-29 |
ECSP10010245A (es) | 2010-07-30 |
MX2010006110A (es) | 2010-06-25 |
JP2011506421A (ja) | 2011-03-03 |
AR069692A1 (es) | 2010-02-10 |
UY31524A1 (es) | 2009-08-03 |
CO6280399A2 (es) | 2011-05-20 |
WO2009074829A1 (en) | 2009-06-18 |
EP2231597A1 (en) | 2010-09-29 |
US20110201581A1 (en) | 2011-08-18 |
EA201000958A1 (ru) | 2010-12-30 |
AU2008334444A1 (en) | 2009-06-18 |
PE20091100A1 (es) | 2009-08-29 |
DOP2010000178A (es) | 2010-09-15 |
CN101945851A (zh) | 2011-01-12 |
AU2008334444B2 (en) | 2011-12-15 |
CL2008003694A1 (es) | 2010-01-15 |
TW200932725A (en) | 2009-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR11492A (es) | Peptidil nitrilos y uso de los mismos como inhibidores de dipeptidil peptidasa i | |
UY32611A (es) | Compuestos de 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
UY31093A1 (es) | Compuestos de ariloazol-2-il cianoetilamino, método para prepararlos y método para utilizarlos | |
UY30976A1 (es) | Nuevos derivados de quinolina, composiciones farmaccuticas que los contienen, procesos de preparacion y aplicaciones. | |
ECSP10010722A (es) | Compuestos orgánicos | |
UY32049A (es) | Inhibidores de cmet | |
UY29795A1 (es) | Derivados de adenina, composiciones farmacéuticas que los contienen, procesos de preparación y aplicaciones | |
ECSP109856A (es) | Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842 | |
GT200600035A (es) | Aminopiridinas como inhibidores de beta-secretasa | |
CO6321189A2 (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida | |
ECSP109945A (es) | Nuevos herbicidas | |
UY31481A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones | |
UY30748A1 (es) | Compuesto0s novedosos | |
CR20140079A (es) | Aminoquinazolinas como inhibidores de quinasa | |
ECSP109942A (es) | Nuevos herbicidas | |
BR112012029647A2 (pt) | novos derivados de pirimidinas | |
ECSP11011245A (es) | Novedosos herbicidas | |
ECSP11011206A (es) | Nuevos herbicidas. | |
UY31905A (es) | Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
UY30488A1 (es) | Bencilaminas,un proceso para su produccion y su uso como agentes anti-inflamatorios. | |
UY29768A1 (es) | Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones | |
UY31479A1 (es) | 5-[(3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-onas, un proceso para su produccion y su uso como agentes antiinflamatorios | |
CR20110381A (es) | Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2 | |
MX2015013365A (es) | Derivados de urea y su uso como inhibidores de proteina de union de acidos grasos (puag). | |
UY32635A (es) | Derivados de bis-(sulfonilamino) en terapia 735 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |